GOELAMS SA4 Study: the Role of Fludarabine in the Treatment of Acute Myeloid Leukemia in the Elderly

NCT00925873 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

303

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Active comparator (no fludarabine)
DRUG: Experimental (fludarabine)

Sponsor

French Innovative Leukemia Organisation

Collaborators

[object Object]
[object Object]